General Chapters – Dosage Forms – Subvisible Expert Panel - Expert Advisor
- Rockville, MD, United States
Applications open in a new tab.
Job details
- Posting language
- English
- Posted
Original job description
2025-2030 Focus:
- Modernize USP guidance for subvisible particulate matter and strengthen science- and risk-based best practices.
- Reimagine the USP <1788> series to better address current products and emerging modalities.
- Clarify particle classification and limits, especially inherent vs. intrinsic/extrinsic particles.
- Address silicone oil droplets, including analytical approaches and FDA feedback. Develop modality-specific approaches for ophthalmics, cell & gene therapy, LNPs, viral vectors, and combination products.
- Advance particle characterization, including sub-10 µm particles, particle ID, and complementary methods beyond light obscuration.
- Connect particles to clinical risk and control strategies, including packaging/device contributions and process sampling.
- Coordinate visible and subvisible particle standards toward a more coherent USP particulate-matter framework.
2025-2030 Key Issues:
- USP <1788> modernization: reimagining the informational chapter series for current and emerging products.
- Particle classification & limits: clarifying inherent, intrinsic, and extrinsic particles and how limits should apply.
- Silicone oil droplets: analytical strategies, characterization, and appropriate USP guidance.
- Emerging modalities: addressing challenges with cell & gene therapies, LNPs, viral vectors, and other complex products.
- Ophthalmics: developing appropriate approaches for subvisible particles in ophthalmic products.
- Measurement & characterization: light obscuration, flow imaging, particle identification, and sub-10 µm particles.
- Packaging & devices: understanding contributions from containers, delivery systems, and packaging components.
- Clinical relevance & risk: connecting particle type, size, source, and quantity with patient risk and appropriate controls.
Required Expertise:
- Particulate matter science: formation, sources, classification, and behavior of inherent, intrinsic, and extrinsic particles.
- Analytical characterization: light obscuration, microscopy, flow imaging, particle identification, orthogonal methods, and sub-10 µm characterization.
- Biologics/protein therapeutics: protein aggregation and inherent proteinaceous particles, particularly where conventional particle limits may not be straightforward.
- Silicone oil: silicone-oil droplets from prefilled syringes, differentiation from protein/other particles, and appropriate analytical strategies.
- Advanced modalities: cell & gene therapies, LNPs, viral vectors, and other products where the product itself can complicate particle measurement.
- Ophthalmic products: formulation, administration route, particle-control expectations, and ophthalmic-specific patient risks.
- Packaging & delivery systems: prefilled syringes, vials, stoppers, devices, container-closure systems, and their potential contribution to particles.
- Clinical/toxicological risk: linking particle size, type, quantity, route of administration, and patient exposure to clinical relevance.
- Manufacturing & process control: particle sources, investigations, PPQ, sampling strategies, trending, root-cause analysis, and lifecycle control.
- Compendial/regulatory standards: strong knowledge of USP particulate-matter chapters and the panel’s work to reimagine the <1788> series for current and emerging products.
More about this job
Skills
- Packaging
- Manufacturing processes
- Root cause analysis